Slingshot members are tracking this event:
Decision on Lilly's (LLY) Olaratumab in Soft Tissue Sarcoma Expected From European Medicines Agency By End of November
Slingshot Insights Explained
Oct 19, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Olaratumab, Soft Tissue Sarcoma, European Medicines Agency, Chmp